EUVIMEDEUVIMED entdecken
Open Access

HCN2 channels: a potential therapeutic target for orofacial n

Toru Yamamoto iD, Tomoaki Ujita iD, Yurie Sato-Yamada iD, Takako Ichiki iD, Naotaka Kishimoto iD, Miho Terunuma iD, Kenji Seo iD

Journal of Oral & Facial Pain and Headache · 2026

DOI: 10.22514/jofph.2026.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oral & Facial Pain and Headache, 2026. Verfasst von Toru Yamamoto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Dental Anesthesiology, Faculty of Dentistry & Graduate School of Medicine and Dental Sciences, Niigata University, 951-8514 Niigata, Japa…. Hauptthemen laut MEDLINE: Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Trigeminal Nerve Injuries, Neuralgia, Facial Pain. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels have recently emerged as promising targets for the treatment of neuropathic pain. This study investigated the potential involvement of HCN2 channels in the development of trigeminal neuropathic pain following peripheral nerve injury. Infraorbital nerve chronic constriction injury (ION-CCI) model was adopted to rats, and head withdrawal thresholds (HWT) to mechanical stimulation were assessed pre- and postoperatively, as well as after pharmacological intervention. In the trigeminal ganglion (TG), intracellular cyclic adenosine monophosphate (cAMP) and cytoplasmic protein kinase A (PKA) levels were quantified by Enzyme-Linked Immunosorbent Assay (ELISA), while Hcn2 mRNA expression was evaluated by quantitative Polymerase Chain Reaction (qPCR). Immunohistochemical analysis was performed to assess phosphorylated cAMP response element-binding protein (pCREB) expression in the TG and HCN2 expression in infraorbital nerve (ION) axons. In the TG, cAMP and pCREB levels were elevated, whereas cytoplasmic PKA and Hcn2 mRNA levels were reduced. Axonal HCN2 expression was increased in CCI rats. On day 14, HWT was significantly reduced following CCI but was ameliorated by local administration of the HCN channel blocker ivabradine at the site of axonal injury. Collectively, these findings suggest that CCI-induced alterations in cAMP-PKA-pCREB signaling promote HCN2 accumulation in injured axons, thereby contributing to the development of orofacial neuropathic pain following peripheral nerve injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsTrigeminal Nerve InjuriesNeuralgiaFacial PainPotassium ChannelsAnimalsRatsMaleRats, Sprague-DawleyCyclic AMP-Dependent Protein KinasesCyclic AMPTrigeminal GanglionDisease Models, Animal

Stichwörter der Autor:innen

Hyperpolarization-activated cyclic nucleotide-gated channelNeuropathic painOrofacialRatTrigeminal

Substanzen

Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsHcn2 protein, ratCyclic AMP-Dependent Protein KinasesPotassium ChannelsCyclic AMP

Autor:innen und Institutionen

  • Division of Dental Anesthesiology, Faculty of Dentistry & Graduate School of Medicine and Dental Sciences, Niigata University, 951-8514 Niigata, Japan.
  • Center for Advanced Oral Science, Faculty of Dentistry & Graduate School of Medicine and Dental Sciences, Niigata University, 951-8514 Niigata, Japan.
  • Department of Oral Biochemistry, Faculty of Dentistry & Graduate School of Medicine and Dental Sciences, Niigata University, 951-8514 Niigata, Japan.

ORCID-Profile: Toru Yamamoto, Tomoaki Ujita, Yurie Sato-Yamada, Takako Ichiki, Naotaka Kishimoto, Miho Terunuma, Kenji Seo

Förderung

  • JSPS KAKENHI

Zitieren

APA

Yamamoto, T., Ujita, T., Sato-Yamada, Y., Ichiki, T., Kishimoto, N., Terunuma, M., & Seo, K. (2026). HCN2 channels: a potential therapeutic target for orofacial n. Journal of Oral & Facial Pain and Headache. https://doi.org/10.22514/jofph.2026.013

Vancouver

Yamamoto T, Ujita T, Sato-Yamada Y, Ichiki T, Kishimoto N, Terunuma M, et al. HCN2 channels: a potential therapeutic target for orofacial n. Journal of Oral & Facial Pain and Headache. 2026. doi:10.22514/jofph.2026.013

BibTeX
@article{Yamamoto2026,
  author = {Yamamoto, Toru and Ujita, Tomoaki and Sato-Yamada, Yurie and Ichiki, Takako and Kishimoto, Naotaka and Terunuma, Miho and Seo, Kenji},
  title = {HCN2 channels: a potential therapeutic target for orofacial n},
  journal = {Journal of Oral & Facial Pain and Headache},
  year = {2026},
  doi = {10.22514/jofph.2026.013}
}
Kostenlos starten →